🇺🇸 FDA
Patent

US 11345659

Pipecolic esters for inhibition of the proteasome

granted A61PA61P35/00

Quick answer

US patent 11345659 (Pipecolic esters for inhibition of the proteasome) held by The Board of Regents of the University of Texas System expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00